Outcomes of limited period of adalimumab treatment in moderate to severe Crohn's disease patients: Taiwan Society of Inflammatory Bowel Disease Study.

Name: Outcomes of limited period of adalimumab treatment in moderate to severe Crohn's disease patients: Taiwan Society of Inflammatory Bowel Disease Study.
Author: Lin, Wei-Chen

Outcomes of limited period of adalimumab treatment in moderate to severe Crohn's disease patients: Taiwan Society of Inflammatory Bowel Disease Study. — المؤلف: Lin, Wei-Chen — Intestinal research Oct 2017

المؤلف: Lin, Wei-Chen
النشر: Intestinal research Oct 2017
الوصف: 487-494 p.